S. Joy

发表

Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients

W. Kraus, G. Ginsburg, D. Voora, 2014, Journal of personalized medicine.

Clinical Pearls and Strategies to Optimize Patient Outcomes

S. Joy, 2008, The Diabetes educator.

Incretin Mimetics as Emerging Treatments for Type 2 Diabetes

P. Rodgers, S. Joy, A. Scates, 2005, The Annals of pharmacotherapy.

Continued Parental Attendance at a Clinic for Adult Survivors of Childhood Cancer

D. Mcneill, I. Ressler, P. Rosoff, 2003, Journal of pediatric hematology/oncology.

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design

G. Ginsburg, Julianne M. O’Daniel, Kensaku Kawamoto, 2012, BMC Health Services Research.

Ruboxistaurin, a Protein Kinase C β Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications

Srilaxmi Bearelly, M. Cooney, S. Bearelly, 2005, The Annals of pharmacotherapy.

Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention

G. Ginsburg, S. Haga, D. Creighton, 2015, Journal of health communication.

Evaluation of the PharmGKB Knowledge Base as a Resource for Efficiently Assessing the Clinical Validity and Utility of Pharmacogenetic Assays

Kensaku Kawamoto, David F. Lobach, Lori A. Orlando, 2009, AMIA.

Tailoring treatment for type 2 diabetes: Uncovering the HOW and NOW of GLP-1 receptor agonist therapy

J. Lasalle, J. Freeman, S. Joy, 2011 .